Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy

Noah Samuels*, Eran Ben-Arye

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Purpose of Review: Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of cancer treatment, with conventional treatment limited in its ability for prevention or treatment of symptoms. This review addresses the research assessing the effectiveness and safety of complementary and integrative medicine (CIM) in preventing and treating CIPN-related symptoms. Recent Findings: The CIM modalities acupuncture, classical massage, omega-3 fatty acids, and the Japanese Kampo medicine Goshanjishen may be of benefit in preventing or treating CIPN. Vitamin E (alpha-tocopherol), glutamine/glutamate, alpha-lipoic acid, and acetyl-l-carnitine (ALCAR) are not, with ALCAR increasing symptom severity and vitamin E the risk for developing prostate cancer. Summary: CIM therapies with a potential for preventing or treating CIPN-related symptoms should be further investigated. CIM is considered safe when provided within an integrative oncology setting, under the guidance and supervision of an integrative physician.

Original languageEnglish
Article number23
JournalCurrent Oncology Reports
Volume22
Issue number3
DOIs
StatePublished - 1 Mar 2020

Keywords

  • Acupuncture
  • Chemotherapy-induced neuropathy
  • Complementary and integrative medicine
  • Dietary supplements
  • Touch therapies

Fingerprint

Dive into the research topics of 'Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy'. Together they form a unique fingerprint.

Cite this